Clincosm LogoSign in Get a demo

Liposarcoma

Showing 1 - 25 of 37
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Engagement Patterns and Participation Trends Among Liposarcoma

Not yet recruiting
  • Liposarcoma
    • San Francisco, California
      Power Life Sciences
    Sep 8, 2023

    Breast Cancer, Ovarian Cancer, Liposarcoma Trial (PF-07224826, Fulvestrant)

    Not yet recruiting
    • Breast Cancer
    • +5 more
    • (no location specified)
    Jun 7, 2023

    NSCLC, Non-Small Cell Lung Adenocarcinoma, Non-Small Cell Squamous Lung Cancer Trial in Grand Rapids, San Antonio, Fairfax

    Recruiting
    • Non-small Cell Lung Cancer
    • +10 more
    • Grand Rapids, Michigan
    • +2 more
    Apr 25, 2023

    Leiomyosarcoma, Liposarcoma, Soft Tissue Sarcoma Adult Trial in Taipei (Eribulin, Lenvatinib)

    Active, not recruiting
    • Leiomyosarcoma
    • +3 more
    • Taipei, Taiwan
    • +1 more
    Dec 27, 2022

    Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma Trial in Worldwide (Surgery, Preoperative chemo)

    Recruiting
    • Retroperitoneal Sarcoma
    • +2 more
    • Surgery
    • Preoperative chemotherapy
    • Woolloongabba, Queensland, Australia
    • +36 more
    Dec 27, 2022

    Liver Cell Carcinoma Trial in Houston (CATCH T cells, Cytoxan, Fludara)

    Recruiting
    • Liver Cell Carcinoma
    • +7 more
    • CATCH T cells
    • +2 more
    • Houston, Texas
      Houston Methodist Hospital
    Dec 19, 2022

    Leiomyosarcoma, Liposarcoma Trial in New York (ATX-101)

    Recruiting
    • Leiomyosarcoma
    • Liposarcoma
    • New York, New York
      Columbia University Irving Medical Center / NewYork-Presbyterian
    Nov 23, 2022

    Liposarcoma, Metastatic Liposarcoma Trial in Boston, Saint Louis, New York (MGCD516)

    Active, not recruiting
    • Liposarcoma
    • Metastatic Liposarcoma
    • Boston, Massachusetts
    • +2 more
    Nov 23, 2022

    Liposarcoma, Osteogenic Sarcoma, Ewing/Ewing-like Sarcoma Trial in United States (Regorafenib, Placebo)

    Completed
    • Liposarcoma
    • +4 more
    • Duarte, California
    • +17 more
    Oct 25, 2022

    Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

    Recruiting
    • Adenocarcinoma
    • +75 more
    • Biomarker Testing (L)
    • +2 more
    • Idaho Falls, Idaho
    • +1 more
    Oct 18, 2022

    Liposarcoma, Malignant Abdominal Tumor, Malignant Retroperitoneal Tumor Trial in Portland (drug, radiation, other, procedure)

    Recruiting
    • Liposarcoma
    • +5 more
    • Eribulin Mesylate
    • +5 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Oct 17, 2022

    Liposarcoma, Myxoid, Sarcoma, Soft Tissue, Leiomyosarcoma Trial in France, Italy, Spain (Trabectedin, Radiotherapy)

    Recruiting
    • Liposarcoma, Myxoid
    • +4 more
    • Bordeaux, France
    • +15 more
    Jun 6, 2022

    Liposarcoma, Atypical Lipomatous Tumor Trial in Montpellier (Blood sampling)

    Recruiting
    • Liposarcoma
    • Atypical Lipomatous Tumor
    • Blood sampling
    • Montpellier, France
      Institut du Cancer de Montpellier - Val d'Aurelle
    Mar 11, 2022

    Liposarcoma, CRC, Prostate Cancer Trial in United States (PF-07220060, Letrozole, Fulvestrant)

    Recruiting
    • Liposarcoma
    • +5 more
    • New Haven, Connecticut
    • +8 more
    Jan 20, 2022

    Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,

    Withdrawn
    • Soft Tissue Sarcoma
    • +12 more
    • Providence, Rhode Island
    • +1 more
    Nov 30, 2021

    Liver Cancer, Rhabdomyosarcoma, Malignant Rhabdoid Tumor Trial in Houston (CARE T cells, Cytoxan, Fludara)

    Not yet recruiting
    • Liver Cancer
    • +5 more
    • CARE T cells
    • +2 more
    • Houston, Texas
      Texas Children's Hospital
    Dec 1, 2021

    Liposarcoma, Leiomyosarcoma Trial in Italy (Trabectedin)

    Completed
    • Liposarcoma
    • Leiomyosarcoma
    • Bari, BA, Italy
    • +20 more
    Oct 29, 2021

    Liposarcoma, Advanced Solid Tumor Trial in Guangzhou, Shanghai (APG-115, Toripalimab)

    Recruiting
    • Liposarcoma
    • Advanced Solid Tumor
    • Guangzhou, Guangdong, China
    • +1 more
    Sep 22, 2021

    Liposarcoma Trial in United States (efatutazone)

    Active, not recruiting
    Has Results
    • Liposarcoma
    • Little Rock, Arkansas
    • +126 more
    Aug 16, 2021

    Sarcoma, Soft Tissue Sarcoma, Metastatic Sarcoma Trial in Providence (Gemcitabine, Docetaxel, 9-ING-41)

    Withdrawn
    • Sarcoma
    • +12 more
    • Providence, Rhode Island
    • +1 more
    Jul 26, 2021

    Liposarcoma Trial in France (Radiotherapy)

    Completed
    Has Results
    • Liposarcoma
    • Radiotherapy
    • Strasbourg, Alsace, France
    • +4 more
    Feb 22, 2021

    Sarcoma, Fibrosarcoma, Leiomyosarcoma Trial in Warsaw (Sequential chemo - 3 courses of AI, Hypofractionated radiotherapy)

    Unknown status
    • Sarcoma
    • +16 more
    • Sequential chemotherapy - 3 courses of AI
    • Hypofractionated radiotherapy
    • Warsaw, Mazovian, Poland
      Maria Sklodowska-Curie Institute - Oncology Center
    Jan 19, 2021

    Liposarcoma Trial in Worldwide (HDM201, LEE011)

    Completed
    • Liposarcoma
    • Toronto, Ontario, Canada
    • +8 more
    Dec 6, 2020

    Liposarcoma, Malignant Peripheral Nerve Sheath Tumors, Alveolar Soft Part Sarcoma Trial in New York (Selinexor, Ixazomib)

    Withdrawn
    • Liposarcoma
    • +4 more
    • New York, New York
      Columbia University Medical Center
    Nov 24, 2020

    Liposarcoma Trial in Nice

    Completed
    • Liposarcoma
      • Nice, France
        Nice Hospital
      Oct 15, 2020